MedPath

The effect of oral miltefosin on treatment resistant cutaneous leishmaniasis

Not Applicable
Conditions
Cutaneous Leishmaniasis Antroponotic.
Cutaneous Leishmaniasis
B55.1
Registration Number
IRCT20200302046673N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
27
Inclusion Criteria

Individuals with antroponotic leishmaniasis over two year who have not received remission despite two courses of systemic glucontime or one cours of systemic glugantime plus one course of intraleasional injection

Exclusion Criteria

Children Under Two Year
Pregnancy and Lactation
Renal Disorer
Liver Disorder
Heart Disease
Cytopenia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endoration Rate of Leasion. Timepoint: Study days 0,14,28,90,180,360. Method of measurement: Ruler.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath